Evidence map›Paper›PMID 25785020›Full record

ArticleInternational journal of clinical and experimental medicine2015

MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.

Zhenfeng Hao, Jishi Yang, Chenghai Wang, Yaoyao Li, Yu Zhang, Xiaoyun Dong, Liulin Zhou, Jing Liu, Yanqing Zhang, Jing Qian

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Role of MicroRNA-7 (MiR-7) in Cancer Physiopathology.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zhenfeng HaoDepartment of Obstetrics and Gynecology, Taixing People's Hospital Affiliated to Yangzhou University Taizhou 225004, Jiangshu, China.
Jishi YangDepartment of Obstetrics and Gynecology, Taixing People's Hospital Affiliated to Yangzhou University Taizhou 225004, Jiangshu, China.
Chenghai WangDepartment of Pathology, Medical College of Yangzhou University Yangzhou 225001, Jiangshu, China.
Yaoyao LiJiangsu Key Laboratory of Intergrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University Yangzhou 225001, Jiangshu, China.
Yu ZhangJiangsu Key Laboratory of Intergrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University Yangzhou 225001, Jiangshu, China.
Xiaoyun DongJiangsu Key Laboratory of Intergrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University Yangzhou 225001, Jiangshu, China.
Liulin ZhouDepartment of Obstetrics and Gynecology, Taixing People's Hospital Affiliated to Yangzhou University Taizhou 225004, Jiangshu, China.
Jing LiuDepartment of Obstetrics and Gynecology, Taixing People's Hospital Affiliated to Yangzhou University Taizhou 225004, Jiangshu, China.
Yanqing ZhangDepartment of Pathology, Medical College of Yangzhou University Yangzhou 225001, Jiangshu, China.
Jing QianJiangsu Key Laboratory of Intergrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University Yangzhou 225001, Jiangshu, China.
Yangzhou University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are aberrantly expressed in cervical cancer. miR-7 has been demonstrated to function as both an oncogene and a tumor suppressor in some types of human cancers. In the present study, miR-7 was significantly downregulated in cervical cancer, especially metastatic tumors. Ectopic expression of miR-7 significantly inhibited metastasis and invasion in Hela and C33A cells. Upregulated miR-7 significantly suppressed focal adhesion kinase (FAK) at transcriptional and translational levels. Furthermore, the level of FAK was negatively correlated with miR-7 in cervical cancer tissues. In conclusion, miR-7 inhibited the metastasis and invasion of cervical cancer at least partially through targeting FAK. The findings of this study provide novel insight with potential therapeutic applications for the treatment of metastatic cervical cancer.

Indexed as

cervical cancerfocal adhesion kinaseinvasionmetastasismicroRNAmiR-7

Identifiers

PMID25785020
PMCPMC4358475
OpenAlexW2401736633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.